Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 11, 2023 07:00 ET | Source: mdf commerce inc.

Le comté de Pima (Arizona) se joint à plus de 6 500 organisations du secteur public ayant choisi la solution « Source-to-contract » de mdf commerce

MONTRÉAL, 11 juill. 2023 (GLOBE NEWSWIRE) -- mdf commerce inc. (TSX : MDF), un leader des technologies de commerce électronique de type logiciel-service (« SaaS »), annonce aujourd’hui que le...
July 10, 2023 09:54 ET | Source: Deep-South Resources Inc

Haib Copper: Licence Renewed

VANCOUVER, British Columbia, July 10, 2023 (GLOBE NEWSWIRE) -- Deep-South Resources Inc. ("Deep-South" or the “Company”) (TSX-V: DSM) announces that the Haib Copper License EPL 3140 has been...
July 10, 2023 07:05 ET | Source: Clearside Biomedical, Inc.

Clearside Biomedical Asia-Pacific Partner Arctic Vision Announces the Acceptance in Australia of its New Drug Application for Suprachoroidal Use of Arcatus® for the Treatment of Uveitic Macular Edema

- XIPERE® is referred to as Arcatus (ARVN001) by Arctic Vision – ALPHARETTA, Ga., July 10, 2023 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company...
July 10, 2023 07:00 ET | Source: Fulcrum Therapeutics, Inc.

Fulcrum Therapeutics Signs Exclusive Global License Agreement in Rare Hematology

CAMBRIDGE, Mass., July 10, 2023 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (NASDAQ: FULC), a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically...
July 06, 2023 17:05 ET | Source: Blue Water Biotech, Inc.

Blue Water Biotech Secures License from Ohio State Board of Pharmacy to Operate as Pharmaceutical Wholesaler for its FDA Approved Products

CINCINNATI, July 06, 2023 (GLOBE NEWSWIRE) -- Blue Water Biotech, Inc. (“Blue Water” or the “Company”) (Nasdaq: BWV), a biotechnology and pharmaceutical company focused on developing and...
July 06, 2023 08:30 ET | Source: Hillstream BioPharma, Inc.

Hillstream BioPharma Licenses Technology to Develop Proprietary HER2 and HER3 Antibody Drug Conjugates against Drug-Resistant Breast, Lung, Gastric, and Ovarian Cancers

Anti-HER2 and Anti-HER3 monoclonal antibodies designed to have a high drug-to-antibody ratio intended enhance the bystander killing effect and be effective against a number of epithelial tumors ...
July 06, 2023 07:30 ET | Source: Blue Water Biotech, Inc.

Blue Water Biotech Teams with BFW Advertising to Market and Advertise Commercial Product Portfolio

CINCINNATI, July 06, 2023 (GLOBE NEWSWIRE) -- Blue Water Biotech, Inc. (“Blue Water” or the “Company”) (Nasdaq: BWV), a biotechnology and pharmaceutical company focused on developing and...
July 06, 2023 06:00 ET | Source: Comstock Inc.

Comstock Announces Mineral Exploration and Mining Lease Revenues

VIRGINIA CITY, Nev., July 06, 2023 (GLOBE NEWSWIRE) -- Comstock Inc. (NYSE: LODE) (“Comstock” and the “Company”), an innovator of technologies that enable systemic decarbonization, today announced...
July 05, 2023 16:05 ET | Source: Heartcore Enterprises Inc.

HeartCore Signs CMS Licensing Agreement with INTRIX, Inc.

NEW YORK and TOKYO, July 05, 2023 (GLOBE NEWSWIRE) -- HeartCore Enterprises, Inc. (Nasdaq: HTCR) (“HeartCore” or “the Company”), a leading software development company offering Customer Experience...
July 05, 2023 08:00 ET | Source: F-star Therapeutics, Inc.

F-star, an invoX Company, Announces Strategic Collaboration and Licence Agreement with Takeda to Discover and Develop Next-Generation Multi-Specific Antibodies

LONDON, July 05, 2023 (GLOBE NEWSWIRE) -- F-star Therapeutics, an invoX company (“F-star”), today announced that it has entered into a strategic discovery collaboration and licence agreement with...